SCHEMBL24324092

SCHEMBL24324092

C[C@@H]1CCCCN1c1cncc(CO)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
KDM4E B2RXH2 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PIM1 P11309 1/20 0.40
PIM3 Q86V86 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
GAA P10253 1/20 0.39
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
SMPD3 Q9NY59 2/20 0.38
LATS1 O95835 1/20 0.37
CHRM4 P08173 2/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
HPGD P15428 1/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C9 P11712 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29600540 1.00 MAPT (0.41) MAPTKDM4EL3MBTL1PIM1PIM3
SCHEMBL29601220 0.96 SMPD3 (0.41) MAPTKDM4EL3MBTL1PIM1PIM3
SCHEMBL24324615 0.96 SMPD3 (0.41) MAPTKDM4EL3MBTL1PIM1PIM3
SCHEMBL1326312 0.78 ALDH1A1 (0.44) MAPTKDM4EL3MBTL1PIM1PIM3
SCHEMBL20436549 0.75 PDE10A (0.48) MAPTKDM4EL3MBTL1BCHEACHE
SCHEMBL24323682 0.74 ALDH1A1 (0.39) MAPTKDM4EL3MBTL1PIM1PIM3
SCHEMBL29600541 0.74 ALDH1A1 (0.39) MAPTKDM4EL3MBTL1PIM1PIM3
SCHEMBL24324093 0.73 PDE10A (0.46) KDM4EPIM1PIM3PIM2ALDH1A1
SCHEMBL24270218 0.73 PDE10A (0.42) MAPTKDM4EL3MBTL1SMPD3CHRM4
SCHEMBL24270217 0.73 PDE10A (0.42) MAPTKDM4EL3MBTL1SMPD3CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed